196 related articles for article (PubMed ID: 35023590)
41. Molecular and functional properties of P2X receptors--recent progress and persisting challenges.
Kaczmarek-Hájek K; Lörinczi E; Hausmann R; Nicke A
Purinergic Signal; 2012 Sep; 8(3):375-417. PubMed ID: 22547202
[TBL] [Abstract][Full Text] [Related]
42. Regulation of P2X Purinergic Receptor Signaling by Cholesterol.
Murrell-Lagnado RD
Curr Top Membr; 2017; 80():211-232. PubMed ID: 28863817
[TBL] [Abstract][Full Text] [Related]
43. P2X receptors in health and disease.
Burnstock G; Kennedy C
Adv Pharmacol; 2011; 61():333-72. PubMed ID: 21586364
[TBL] [Abstract][Full Text] [Related]
44. Contribution of calcium ions to P2X channel responses.
Egan TM; Khakh BS
J Neurosci; 2004 Mar; 24(13):3413-20. PubMed ID: 15056721
[TBL] [Abstract][Full Text] [Related]
45. Contribution of P2X purinergic receptor in cerebral ischemia injury.
Zhang WJ; Hu DX; Lin SJ; Fang XQ; Ye ZF
Brain Res Bull; 2022 Nov; 190():42-49. PubMed ID: 36113681
[TBL] [Abstract][Full Text] [Related]
46. A Highly Conserved Salt Bridge Stabilizes the Kinked Conformation of β2,3-Sheet Essential for Channel Function of P2X4 Receptors.
Zhao WS; Sun MY; Sun LF; Liu Y; Yang Y; Huang LD; Fan YZ; Cheng XY; Cao P; Hu YM; Li L; Tian Y; Wang R; Yu Y
J Biol Chem; 2016 Apr; 291(15):7990-8003. PubMed ID: 26865631
[TBL] [Abstract][Full Text] [Related]
47. ATP-gated P2X cation-channels.
Jarvis MF; Khakh BS
Neuropharmacology; 2009 Jan; 56(1):208-15. PubMed ID: 18657557
[TBL] [Abstract][Full Text] [Related]
48. A conserved residue in the P2X4 receptor has a nonconserved function in ATP recognition.
Chen PF; Ma XF; Sun LF; Tian Y; Fan YZ; Li P; Xiao Z; Zhu MX; Guo CR; Li C; Yu Y; Wang J
J Biol Chem; 2021; 296():100655. PubMed ID: 33901491
[TBL] [Abstract][Full Text] [Related]
49. Inherent dynamics of head domain correlates with ATP-recognition of P2X4 receptors: insights gained from molecular simulations.
Huang LD; Fan YZ; Tian Y; Yang Y; Liu Y; Wang J; Zhao WS; Zhou WC; Cheng XY; Cao P; Lu XY; Yu Y
PLoS One; 2014; 9(5):e97528. PubMed ID: 24878662
[TBL] [Abstract][Full Text] [Related]
50. Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel.
Kasuya G; Yamaura T; Ma XB; Nakamura R; Takemoto M; Nagumo H; Tanaka E; Dohmae N; Nakane T; Yu Y; Ishitani R; Matsuzaki O; Hattori M; Nureki O
Nat Commun; 2017 Oct; 8(1):876. PubMed ID: 29026074
[TBL] [Abstract][Full Text] [Related]
51. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
[TBL] [Abstract][Full Text] [Related]
52. Gating mechanism of a P2X4 receptor developed from normal mode analysis and molecular dynamics simulations.
Du J; Dong H; Zhou HX
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4140-5. PubMed ID: 22378652
[TBL] [Abstract][Full Text] [Related]
53. Architectural and functional similarities between trimeric ATP-gated P2X receptors and acid-sensing ion channels.
Kellenberger S; Grutter T
J Mol Biol; 2015 Jan; 427(1):54-66. PubMed ID: 24937752
[TBL] [Abstract][Full Text] [Related]
54. Pore-opening mechanism in trimeric P2X receptor channels.
Li M; Kawate T; Silberberg SD; Swartz KJ
Nat Commun; 2010 Jul; 1(4):44. PubMed ID: 20975702
[TBL] [Abstract][Full Text] [Related]
55. Characterization of ionotrophic purinergic receptors in hepatocytes.
Emmett DS; Feranchak A; Kilic G; Puljak L; Miller B; Dolovcak S; McWilliams R; Doctor RB; Fitz JG
Hepatology; 2008 Feb; 47(2):698-705. PubMed ID: 18027885
[TBL] [Abstract][Full Text] [Related]
56. Purinergic P2X receptors: structural and functional features depicted by X-ray and molecular modelling studies.
Grimes L; Young MT
Curr Med Chem; 2015; 22(7):783-98. PubMed ID: 25312208
[TBL] [Abstract][Full Text] [Related]
57. Salt bridge switching from Arg290/Glu167 to Arg290/ATP promotes the closed-to-open transition of the P2X2 receptor.
Hausmann R; Günther J; Kless A; Kuhlmann D; Kassack MU; Bahrenberg G; Markwardt F; Schmalzing G
Mol Pharmacol; 2013 Jan; 83(1):73-84. PubMed ID: 23041661
[TBL] [Abstract][Full Text] [Related]
58. The P2Y/P2X divide: How it began.
Kennedy C
Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
[TBL] [Abstract][Full Text] [Related]
59. Modulation of Central Synapses by Astrocyte-Released ATP and Postsynaptic P2X Receptors.
Boué-Grabot E; Pankratov Y
Neural Plast; 2017; 2017():9454275. PubMed ID: 28845311
[TBL] [Abstract][Full Text] [Related]
60. Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists.
Sheng D; Yue CX; Jin F; Wang Y; Ichikawa M; Yu Y; Guo CR; Hattori M
Elife; 2024 Apr; 12():. PubMed ID: 38578670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
